1ST CLINICAL-EXPERIENCE WITH LOW-MOLECULAR-WEIGHT HEPARIN LU-47311 (REVIPARIN) FOR PREVENTION OF RESTENOSIS AFTER PERCUTANEOUS TRANSLUMINALCORONARY ANGIOPLASTY

Authors
SCHMID KM PREISACK M VOELKER W SUJATTA M KARSCH KR
Citation
Km. Schmid et al., 1ST CLINICAL-EXPERIENCE WITH LOW-MOLECULAR-WEIGHT HEPARIN LU-47311 (REVIPARIN) FOR PREVENTION OF RESTENOSIS AFTER PERCUTANEOUS TRANSLUMINALCORONARY ANGIOPLASTY, Seminars in thrombosis and hemostasis, 19, 1993, pp. 155-159
Citations number
42
Categorie Soggetti
Hematology,"Cardiac & Cardiovascular System
Journal title
Seminars in thrombosis and hemostasis → ACNP
ISSN journal
00946176
Volume
19
Year of publication
1993
Supplement
1
Pages
155 - 159
Database
ISI
SICI code
0094-6176(1993)19:<155:1CWLHL>2.0.ZU;2-U